Home › NDC Lookup › RxCUI directory › RxCUI 2690290

Carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule — RxCUI 2690290

RxNorm drug concept · Semantic clinical drug
RxCUI 2690290 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2690290
Official nameCarbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascarbidopa 87.5 MG / L-DOPA 350 MG Extended Release Oral Capsule
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)1,377 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levodopa and Carbidopa: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Levodopa is the medicine that actually works in your brain — it crosses into the brain and gets converted into dopamine, the chemical that Parkinson's disease depletes. The problem...
  • What exactly does levodopa and carbidopa do, and why do I need both?
  • Generally yes, but the timing and content of your meals can matter. High-protein foods — like large servings of meat, eggs, or dairy — can compete with levodopa for absorption in y...
  • Can I eat normally while taking this medication?
📖 Read our full Levodopa and Carbidopa guide →

🕸️ Concept Web — How Carbidopa 87.5 MG / levodopa 350 MG Extended Rel... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule RxCUI 2690290

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Carbidopa 2019
    • Levodopa 6375
    • Carbidopa / levodopa 103990
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Crexont 2690260
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Carbidopa / levodopa Extended Release Oral Capsule 1599243
    • Carbidopa / levodopa Oral Product 1155774
    • Carbidopa / levodopa Pill 1155775
    • Carbidopa / levodopa Extended Release Oral Capsule [Crexont] 2690264
    • Crexont Oral Product 2690262
    • Crexont Pill 2690263
    • Extended Release Oral Capsule 316943
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Carbidopa 87.5 MG SCDC · 2690288
  • Levodopa 350 MG SCDC · 2690289
  • Carbidopa / levodopa Extended Release Oral Capsule SCDF · 1599243
  • Carbidopa / levodopa Oral Product SCDG · 1155774
  • Carbidopa / levodopa Pill SCDG · 1155775

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 2690290 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64896-0967-16 1 BOTTLE in 1 CARTON (64896-967-16) / 120 CAPSULE, EXTENDED... CREXONT Amneal Pharmaceuticals LLC 2024-08-09
64896-0967-23 1 BOTTLE in 1 CARTON (64896-967-23) / 120 CAPSULE, EXTENDED... CREXONT Amneal Pharmaceuticals LLC 2024-08-09
64896-0968-16 1 BOTTLE in 1 CARTON (64896-968-16) / 120 CAPSULE, EXTENDED... CREXONT Amneal Pharmaceuticals LLC 2024-08-09
64896-0968-23 1 BOTTLE in 1 CARTON (64896-968-23) / 120 CAPSULE, EXTENDED... CREXONT Amneal Pharmaceuticals LLC 2024-08-09
64896-0969-16 1 BOTTLE in 1 CARTON (64896-969-16) / 120 CAPSULE, EXTENDED... CREXONT Amneal Pharmaceuticals LLC 2024-08-09
64896-0969-23 1 BOTTLE in 1 CARTON (64896-969-23) / 120 CAPSULE, EXTENDED... CREXONT Amneal Pharmaceuticals LLC 2024-08-09
64896-0970-16 1 BOTTLE in 1 CARTON (64896-970-16) / 120 CAPSULE, EXTENDED... CREXONT Amneal Pharmaceuticals LLC 2024-08-09
64896-0970-23 1 BOTTLE in 1 CARTON (64896-970-23) / 120 CAPSULE, EXTENDED... CREXONT Amneal Pharmaceuticals LLC 2024-08-09
Observed labelers: Amneal Pharmaceuticals LLC (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.